Development of novel microbial synthetic consortia for the production of antimicrobial fermentates containing caproate
Authors:
Open Access
- 27 February 2026
- journal article
- research article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 110 (1) , 85
Abstract
Short- and medium chain carboxylic acids (SCCA/MCCA) are natural antimicrobials produced by fermentation and chain elongation, but currently only a few SCCA/MCCA are used in food-related applications. With the aim to diversify the SCCA/MCCA profile of fermentates for biopreservation, we designed bioprocesses employing bacterial or multi-kingdom consortia to produce caproate-containing fermentates using a targeted cross-feeding strategy. We combined Limosilactobacillus reuteri, Clostridium kluyveri, and Saccharomyces cerevisiae , and quantified substrates utilization and metabolites. The antimicrobial activity of SCCA/MCCA and fermentates was analysed in vitro and in a meat model system. In a first bioprocess, the addition of ethanol (EtOH) initiated caproate formation by the bacterial consortium with levels of 63.9 mM (7.4 g L −1 ) after 22 days. Next, we run two shorter bioprocesses (12 days) and more caproate (28.9 mM, 3.4 g L −1 ) was produced if EtOH was regularly added than without EtOH supplementation (21.7 mM, 2.5 g L −1 ). When S. cerevisiae was included, 37.9 ± 11.4 mM (4.4 g L −1 ) caproate was formed without EtOH addition. Beyond the intended cross-feeding activity, consortia produced and re-metabolised mannitol and glycerol. Lactate and caproate were the major carboxylic acids in fermentates. Caproate inhibited bacteria, yeast and molds at pH 4.5 and 6.5 in vitro, while lactate and caproate acted synergistically in minced meat. Fermentates conferred antimicrobial activity against indicator microbes mostly at pH 4.5 and to a lesser extent at pH 6.5. In this study we successfully designed a consortium to produce caproate. We provide evidence that caproate-containing fermentates had strong antimicrobial activity, and our results indicate the complexity of metabolic interactions that occurred within consortium members. Key points: • Design of a self-contained bioprocess with multi-kingdom consortium. • Cross-feeding of bacteria and yeast to produce caproate fermentates. • Fermentates containing caproate inhibited bacteria, yeast and mold growth.Keywords
Funding Information
- Novo Nordisk Fonden (NNF21OC0066725)
- Aarhus Universitet
This publication has 41 references indexed in Scilit:
- Lactobacillus reuteri DSM 20016 Produces Cobalamin-Dependent Diol Dehydratase in Metabolosomes and Metabolizes 1,2-Propanediol by DisproportionationJournal of Bacteriology, 2008
- The genome ofClostridium kluyveri, a strict anaerobe with unique metabolic featuresProceedings of the National Academy of Sciences of the United States of America, 2008
- Quantitative real time PCR assays for the enumeration of Saccharomyces cerevisiae and the Saccharomyces sensu stricto complex in human fecesJournal of Microbiological Methods, 2007
- Mechanisms of water-holding capacity of meat: The role of postmortem biochemical and structural changesMeat Science, 2005
- Effect of glucose on glycerol bioconversion by Lactobacillus reuteriApplied Microbiology and Biotechnology, 2002
- Osmoregulation and glycerol metabolism in the yeastSaccharomyces cerevisiaeFEMS Microbiology Reviews, 1997
- Production of caproic acid by cocultures of ruminal cellulolytic bacteria and Clostridium kluyveri grown on cellulose and ethanolApplied Microbiology and Biotechnology, 1995
- Enhanced fermentation of mannitol and release of cytotoxin by Clostridium difficile in alkaline culture mediaApplied and Environmental Microbiology, 1995
- 13C NMR studies of butyric fermentation in Clostridium kluyveri.Journal of Biological Chemistry, 1985
- THE ENERGY METABOLISM OF CLOSTRIDIUM KLUYVERI AND THE SYNTHESIS OF FATTY ACIDSJournal of Biological Chemistry, 1948